Tsujino, T., Tokushige, S., Komura, K., Fukuokaya, W., Adachi, T., Hirasawa, Y., . . . Azuma, H. (2023). Real‑world survival outcome comparing abiraterone acetate plus prednisone and enzalutamide for nonmetastatic castration‐resistant prostate cancer. Wiley.
Chicago Style (17th ed.) CitationTsujino, Takuya, et al. Real‑world Survival Outcome Comparing Abiraterone Acetate Plus Prednisone and Enzalutamide for Nonmetastatic Castration‐resistant Prostate Cancer. Wiley, 2023.
MLA (9th ed.) CitationTsujino, Takuya, et al. Real‑world Survival Outcome Comparing Abiraterone Acetate Plus Prednisone and Enzalutamide for Nonmetastatic Castration‐resistant Prostate Cancer. Wiley, 2023.
Warning: These citations may not always be 100% accurate.